The Korea Electrotechnology Research Institute (KERI) has developed a device that allows clothes and shoes to produce electricity using their frictional forces and to store it.
The device has a self-charging nanogenerator that produces electricity using frictional force and has a micro super-capacitor power supply that stores the electricity and supplies it to other wearable electronic devices.
The KERI adopted the method of integrating single-wall carbon nanotubes, which have excellent electrical conductivity, with elastic polymers.
The newly-developed device is elastic in all directions while having strong enough durability to endure more than 10,000 uses in KERI’s in-house performance tests.
A possible application would be for hiking or climbing apparel that charges power supply devices to be used for flashlights and smartphones in emergencies.


Gold Prices Steady as Markets Await Key U.S. Data and Expected Fed Rate Cut
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
China’s Services Sector Posts Slowest Growth in Five Months as Demand Softens
Asian Markets Mixed as RBI Cuts Rates and BOJ Signals Possible Hike
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Lab-grown meat: you may find it icky, but it could drive forward medical research
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
European Stocks Rise as Markets Await Key U.S. Inflation Data
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure
Citi Sets Bullish 2026 Target for STOXX 600 as Fiscal Support and Monetary Easing Boost Outlook
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



